Asarfi Hospital Ltd — Important, 30-05-2026: Company Update

Asarfi Hospital submitted the transcript of its Q4 & FY26 earnings conference call, where audited financial results were discussed. For FY26, consolidated revenue grew 42% to 173.5 Cr, EBITDA rose 42% to 35.3 Cr (20% margin), and PAT increased 58% to 16.7 Cr (10% margin). Q4 revenue was 45.2 Cr, with EBITDA at 7.7 Cr (17% margin) and PAT at 3.9 Cr. The company targets 400 Cr revenue and 500+ beds by 2028, driven by cancer hospital expansion from 65 to 150 beds. Bone marrow unit launch is delayed due to state policy issues but expected in 4-5 months. Management aims for 260 Cr revenue and 22% EBITDA margin in FY27, with main board migration planned post-July.